Red Flags Detected
- Goodwill Impairment (worsened) — Best Buy Health recorded $118M goodwill impairment in FY2026 (down from $475M in FY2025), but underlying business deteriorated with customer base changes and Medicaid/Medicare Advantage market pressures.
Best Buy returns to sales growth, scales Marketplace and Ads, but tariff refunds uncertain
Filed March 18, 2026 · Period ending January 31, 2026 · Compared to 10-K Mar 19, 2025 · ~2 min read
Key Changes
-
high
Comparable sales grew 0.5% in FY2026 after declining 2.3% in FY2025, driven by computing and mobile phones. Revenue reached $41.7B, up from $41.5B, marking an inflection from multi-year declines.
MD&A: Comparable Sales verify on EDGAR → -
high
Supreme Court ruled IEEPA tariffs unauthorized in February 2026, but refund timing and recoverability remain uncertain. Company's supply chain heavily dependent on imports from China, Mexico, and Southeast Asia.
MD&A: Tariff Developments verify on EDGAR → -
high
Best Buy Marketplace launched in FY2026, generating commission and advertising revenue without inventory investment. Company plans to expand seller count and invest in technology and advertising in FY2027.
MD&A: Marketplace Launch verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SMID 10-Q) is open in full — no account needed.
Partner
Trade BBY commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 11, 2026 5:11 AM